BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 38437665)

  • 1. The dilemma of radiation necrosis from diagnosis to treatment in the management of brain metastases.
    Mayo ZS; Billena C; Suh JH; Lo SS; Chao ST
    Neuro Oncol; 2024 Mar; 26(12 Suppl 2):S56-S65. PubMed ID: 38437665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of symptomatic radiation necrosis in patients treated with stereotactic radiosurgery for brain metastases.
    Sayan M; Şahin B; Mustafayev TZ; Kefelioğlu EŞS; Vergalasova I; Gupta A; Balmuk A; Güngör G; Ohri N; Weiner J; Karaarslan E; Özyar E; Atalar B
    Neurocirugia (Astur : Engl Ed); 2021; 32(6):261-267. PubMed ID: 34743823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation Necrosis from Stereotactic Radiosurgery-How Do We Mitigate?
    Vellayappan BA; McGranahan T; Graber J; Taylor L; Venur V; Ellenbogen R; Sloan AE; Redmond KJ; Foote M; Chao ST; Suh JH; Chang EL; Sahgal A; Lo SS
    Curr Treat Options Oncol; 2021 Jun; 22(7):57. PubMed ID: 34097171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging changes over 18 months following stereotactic radiosurgery for brain metastases: both late radiation necrosis and tumor progression can occur.
    Fujimoto D; von Eyben R; Gibbs IC; Chang SD; Li G; Harsh GR; Hancock S; Fischbein N; Soltys SG
    J Neurooncol; 2018 Jan; 136(1):207-212. PubMed ID: 29098569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First follow-up radiographic response is one of the predictors of local tumor progression and radiation necrosis after stereotactic radiosurgery for brain metastases.
    Sharma M; Jia X; Ahluwalia M; Barnett GH; Vogelbaum MA; Chao ST; Suh JH; Murphy ES; Yu JS; Angelov L; Mohammadi AM
    Cancer Med; 2017 Sep; 6(9):2076-2086. PubMed ID: 28776956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases?
    Colaco RJ; Martin P; Kluger HM; Yu JB; Chiang VL
    J Neurosurg; 2016 Jul; 125(1):17-23. PubMed ID: 26544782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the Spectrum of Radiation Necrosis After Stereotactic Radiosurgery (SRS) for Intracranial Metastases From Lung Cancer: A Retrospective Review.
    Sharma A; Mountjoy LJ; Butterfield RJ; Zhang N; Ross HJ; Schild SE; Sio TT; Daniels TB; Paripati HR; Mrugala MM; Vora SA; Patel NP; Zimmerman RS; Ashman JB; Porter AB
    Am J Clin Oncol; 2020 Feb; 43(2):128-132. PubMed ID: 31764021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic radiation necrosis in brain metastasis patients treated with stereotactic radiosurgery and immunotherapy.
    Weingarten N; Kruser TJ; Bloch O
    Clin Neurol Neurosurg; 2019 Apr; 179():14-18. PubMed ID: 30784894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery.
    Stockham AL; Tievsky AL; Koyfman SA; Reddy CA; Suh JH; Vogelbaum MA; Barnett GH; Chao ST
    J Neurooncol; 2012 Aug; 109(1):149-58. PubMed ID: 22638727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies.
    Kim JM; Miller JA; Kotecha R; Xiao R; Juloori A; Ward MC; Ahluwalia MS; Mohammadi AM; Peereboom DM; Murphy ES; Suh JH; Barnett GH; Vogelbaum MA; Angelov L; Stevens GH; Chao ST
    J Neurooncol; 2017 Jun; 133(2):357-368. PubMed ID: 28434110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.
    Milano MT; Grimm J; Niemierko A; Soltys SG; Moiseenko V; Redmond KJ; Yorke E; Sahgal A; Xue J; Mahadevan A; Muacevic A; Marks LB; Kleinberg LR
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):68-86. PubMed ID: 32921513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extent of perilesional edema differentiates radionecrosis from tumor recurrence following stereotactic radiosurgery for brain metastases.
    Leeman JE; Clump DA; Flickinger JC; Mintz AH; Burton SA; Heron DE
    Neuro Oncol; 2013 Dec; 15(12):1732-8. PubMed ID: 24243914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a questionnaire regarding practice patterns for the diagnosis and treatment of intracranial radiation necrosis after SRS.
    Stockham AL; Ahluwalia M; Reddy CA; Suh JH; Kumar A; Vogelbaum MA; Barnett GH; Murphy ES; Chao ST
    J Neurooncol; 2013 Dec; 115(3):469-75. PubMed ID: 24045970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric Factors Related to Radiation Necrosis After 5-Fraction Radiosurgery for Patients With Resected Brain Metastases.
    Tanenbaum DG; Buchwald ZS; Jhaveri J; Schreibmann E; Switchenko JM; Prabhu RS; Chowdhary M; Abugideiri M; Pfister NT; Eaton B; Kahn SE; Olson JJ; Shu HG; Crocker IR; Curran WJ; Patel KR
    Pract Radiat Oncol; 2020; 10(1):36-43. PubMed ID: 31586666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse radiation effect and freedom from progression following repeat stereotactic radiosurgery for brain metastases.
    Sneed PK; Chan JW; Ma L; Braunstein SE; Theodosopoulos PV; Fogh SE; Nakamura JL; Boreta L; Raleigh DR; Ziemer BP; Morin O; Hervey-Jumper SL; McDermott MW
    J Neurosurg; 2023 Jan; 138(1):104-112. PubMed ID: 35594891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Fraction Versus Multifraction (3 × 9 Gy) Stereotactic Radiosurgery for Large (>2 cm) Brain Metastases: A Comparative Analysis of Local Control and Risk of Radiation-Induced Brain Necrosis.
    Minniti G; Scaringi C; Paolini S; Lanzetta G; Romano A; Cicone F; Osti M; Enrici RM; Esposito V
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1142-8. PubMed ID: 27209508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-stereotactic radiosurgery brain metastases: a review.
    Fabiano AJ; Qiu J
    J Neurosurg Sci; 2015 Jun; 59(2):157-67. PubMed ID: 25600555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
    Loo M; Pin Y; Thierry A; Clavier JB
    Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.